Obesity is a world-wide epidemic of increasing interest to news outlets around the globe.
Keeping You Informed
The Communications Department at The Obesity Society (TOS) regularly publishes press releases and other materials to keep the media and the public actively informed. Materials distributed to the press discuss developments at TOS as well as a variety of obesity-related topics and issues, including ObesityWeek®.
Recent Press Releases
2026
The Obesity Society Statement On New Dietary Guidelines – January 7, 2026
BALANCE Model Statement – January 7, 2026
2025
TOS Statement on White House Announcement Regarding Lower-Cost Obesity Medications – November 7, 2025
From GLP-1s to Food Policy: ObesityWeek® 2025 Opens Registration for In-Person and Virtual Media – October 14, 2025
Inside the Fight Over Food, Funding, and Fairness: ObesityWeek® 2025 Tackles the Biggest Policy and Economic Controversies in Obesity Care – October 7, 2025
Discover the GLP-1 Revolution at ObesityWeek® 2025 in Atlanta – September 29, 2025
Discover the Future of Obesity Science: Media Invited to ObesityWeek® 2025 in Atlanta – September 19, 2025
Leading Health Organizations Call for Nutrition Education to Become a Core Part of Medical Training – September 9, 2025
The Obesity Society Expands Leadership Team Under New CEO – July 23, 2025
New CMPI Report Finds FDA Inaction on Illegal GLP-1 Compounding Threatens U.S. Patients – July 22, 2025
The Obesity Society Announces New CEO – June 2, 2025
Nutritional Priorities to Support GLP-1 Therapy for Obesity – May 30, 2025
TOS Statement on “Weight Stigma and Bias: Standards of Care in Overweight and Obesity—2025” – May 19, 2025
TOS Statement on Oral GLP-1s – April 22, 2025
CMS decision on obesity medications leaves gap in health care access for millions of Americans – April 7, 2025
The Obesity Society hosts briefing on compounded GLP-1s and the need for FDA enforcement – March 21, 2025
The Obesity Society to host scientific and regulatory briefing on compounded GLP-1s and patient safety, March 13, 2025
The Obesity Society commends FDA’s resolution of obesity drug shortages, calls for enforcement against unauthorized compounding, February 26, 2025
Ad perpetuates obesity stigma for patients in need of safe and effective medications, February 7, 2025
The Obesity Society Applauds the Work of The Lancet Diabetes & Endocrinology Commission on Diagnostic Criteria of Clinical Obesity, January 15, 2025
70+ Groups: Trump Administration Should Expand Obesity Medication Access, January 13, 2025
2024
ObesityWeek® Research on Nov. 3 Demonstrates Gaps in Drug Labeling for People with Obesity, November 4, 2024
The Obesity Society Welcomes Sherlyn Celone-Arnold to the Team, October 17, 2024
Building Momentum in the Prevention and Treatment of Childhood Obesity as TOS Recognizes National Childhood Obesity Awareness Month, but More Work Needs to be Done, September 10, 2024
Discover Connections Between Research, Clinical Practice, and Community at ObesityWeek®, August 14, 2024
Experts Develop Nutritional Recommendations for Patients Treated with Anti-Obesity Medications, June 10, 2024
Study: Physical Activity in the Evening Lowers Blood Sugar Levels, June 10, 2024
Excessive Pregnancy Weight Gain and Substantial Postpartum Weight Retention Common in Military Health Care Beneficiaries, April 23, 2024
New Data Analysis Supports Hedonic Overdrive Model in High-Fat Diet-Induced Mice, February 27, 2024
Study: Whether You Exercise Regularly or One-to-Two Days A Week, Weight Loss is Possible, February 20, 2024
National Academy of Medicine member new president of The Obesity Society, February 1, 2024